ConductScience.org, home

Paper42903410PubMed

Targeting lysine acetyltransferase 6A/B in cancer: a conceptual and translational review of epigenetic regulation, immune microenvironment remodeling, and the dual-compartment hypothesis.

Ma C and 4 others. Front Immunol, 2026.

Cite this record

ConductScience Library. Targeting lysine acetyltransferase 6A/B in cancer: a conceptual and translational review of epigenetic regulation, immune microenvironment remodeling, and the dual-compartment hypothesis. Papers, record 42903410. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42903410

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting lysine acetyltransferase 6A/B in cancer: a conceptual and translational review of epigenetic regulation, immune microenvironment remodeling, and the dual-compartment hypothesis.
Journal
Front Immunol
Year
2026
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
Revised in PubMed
2026-10-27

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ma CCong
2Wang JJingru
3Qiao GGuanhua
4Wu XXinhong
5Zheng HHongmei

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
Epigenesis, GeneticMajor topic
NeoplasmsMajor topic
Histone AcetyltransferasesMajor topic
Lysine AcetyltransferasesMajor topic
Humans
Animals
Proteolysis Targeting Chimera
Gene Expression Regulation, Neoplastic
Antineoplastic Agents

Source PubMed

Download CSV of topics

References117

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
141611522Biological Activity and Structural Biology of Current KAT6A Inhibitor Chemotypes.J Med Chem2026https://conductscience.org/library/papers/41611522PubMed
230069049Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth.Nature2018https://conductscience.org/library/papers/30069049PubMed
328197390The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200.Oncoimmunology2017https://conductscience.org/library/papers/28197390PubMed
437058271SNORD17-mediated KAT6B mRNA 2'-O-methylation regulates vasculogenic mimicry in glioblastoma cells.Cell Biol Toxicol2023https://conductscience.org/library/papers/37058271PubMed
540580997Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors.Oncologist2025https://conductscience.org/library/papers/40580997PubMed
617320507Chromatin modifications and their function.Cell2007https://conductscience.org/library/papers/17320507PubMed
735432536KAT6B May Be Applied as a Potential Therapeutic Target for Glioma.J Oncol2022https://conductscience.org/library/papers/35432536PubMed
841326356Immune cells dying from ferroptosis: mechanisms and therapeutic opportunities.Cell Death Dis2025https://conductscience.org/library/papers/41326356PubMed
927653692Acetylation of the Cd8 Locus by KAT6A Determines Memory T Cell Diversity.Cell Rep2016https://conductscience.org/library/papers/27653692PubMed
1023063713Tandem PHD fingers of MORF/MOZ acetyltransferases display selectivity for acetylated histone H3 and are required for the association with chromatin.J Mol Biol2012https://conductscience.org/library/papers/23063713PubMed
1129443960TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Nature2018https://conductscience.org/library/papers/29443960PubMed
1229937226LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.Cell2018https://conductscience.org/library/papers/29937226PubMed
1338824244Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial.Nat Med2024https://conductscience.org/library/papers/38824244PubMed
1437495688Rewiring cancer drivers to activate apoptosis.Nature2023https://conductscience.org/library/papers/37495688PubMed
1538973255KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38973255PubMed
1624984779Writers and readers of histone acetylation: structure, mechanism, and inhibition.Cold Spring Harb Perspect Biol2014https://conductscience.org/library/papers/24984779PubMed
1738890285The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma.Cell Death Dis2024https://conductscience.org/library/papers/38890285PubMed
1839825161The important role of the histone acetyltransferases p300/CBP in cancer and the promising anticancer effects of p300/CBP inhibitors.Cell Biol Toxicol2025https://conductscience.org/library/papers/39825161PubMed
1941361170ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer.Nat Commun2025https://conductscience.org/library/papers/41361170PubMed
2038383216Histone lysine acetyltransferase inhibitors: an emerging class of drugs for cancer therapy.Trends Pharmacol Sci2024https://conductscience.org/library/papers/38383216PubMed

See all 117 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42903410

GET https://conductscience.org/api/papers/v1/42903410/references?page=2